Volume 18, Number 12—December 2012
MRSA Variant in Companion Animals
Methicillin-resistant Staphylocoocus aureus (MRSA) harboring mecALGA251 has been isolated from humans and ruminants. Database screening identified this MRSA variant in cats, dogs, and a guinea pig in Germany during 2008–2011. The novel MRSA variant is not restricted to ruminants or humans, and contact with companion animals might pose a zoonotic risk.
Worldwide, methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of infectious diseases in humans and animals (1). The staphylococcal cassette chromosome mec (SCCmec) harbors the mecA gene, which encodes an additional penicillin-binding protein 2a. In the presence of β-lactam antimicrobial drugs, this transpeptidase substitutes an essential cross-linking step in the process of cell-wall building (2). Eleven distinct SCCmec elements have been described (3). Recent reports of MRSA carrying a novel mecA homologue (mecALGA251) of a predicted amino acid identity of 62% with other mecA allotypes raised awareness about these pathogens, which possibly remain undetected by conventional PCR approaches (3–5). This lack of detection might have led to underestimation of the novel MRSA variant among clinical samples of human and animal origin.
High-level congruence between S. aureus of animal and human lineages has been demonstrated (6), and nearly every sequence type (ST) reported for MRSA associated with infections in companion animals was also commonly found in humans (1). Because previous reports indicated that MRSA harboring mecALGA251 originated from either human or ruminant hosts (3–5), we searched our database for companion animal isolates that displayed a MRSA phenotype but had failed to give a positive PCR result for mecA.
From November 2008 through December 2011, MRSA of companion animal origin was routinely isolated from specimens submitted for diagnostic purposes to Vet Med Labor GmbH in Ludwigsburg, Germany, or to the Institute of Microbiology and Epizootics, Freie Universität Berlin, in Berlin, Germany. S. aureus was confirmed as described (7) and stored in glycerol stocks at −80°C.
PCR routinely used to confirm methicillin resistance and species identity had failed to produce a positive signal for mecA in 10 MRSA isolates from companion animals (2 isolates from dogs, 7 from cats, and 1 from a guinea pig) (8). We screened these 10 isolates for the mecA homologue by using the PCR method published by Cuny et al. (5) and sent the amplicons obtained to LGC Genomics GmbH (Berlin, Germany) for sequencing. Automated antimicrobial drug susceptibility testing was performed by using the bioMérieux VITEK 2 system (Nürtingen, Germany) according to the manufacturer’s instructions. The following drugs were tested according to Clinical and Laboratory Standards Institute guidelines M31–A3: penicillin, ampicillin–sulbactam, oxacillin, gentamicin, kanamycin, enrofloxacin, marbofloxacin, erythromycin, clindamycin, tetracycline, nitrofurantoin, chloramphenicol, and trimethoprim–sulfamethoxazole, (9). All isolates were further characterized by spa typing, multilocus sequence typing, and microarray hybridization by using the Alere Identibac S. aureus Genotyping chip (Alere Technologies GmbH, Jena, Germany) as described (10–12).
The presence of the mecA homologue was verified for all 10 isolates. All PCR amplicons demonstrated 100% identity with the DNA sequence of mecALGA251 (National Center for Biotechnology Information no. FR821779.1). The strains originated from geographically diverse areas (5 federal states of Germany) and were isolated from different infection sites (Table). All strains were identified as MRSA by the VITEK 2 system (growth in the presence of 6 μg/mL cefoxitin according to the VITEK 2 Advanced Expert System), although oxacillin MICs were rather low (0.5 μg/mL) or moderately high (≥4 μg/mL) (Table). Phenotypic resistance toward non–β-lactams was not detected.
As has been described for atypical MRSA, 4 strains belonged to ST130 and 1 strain belonged to ST1945 (differs from ST130 by 1 allele) (3–5). The remaining 5 isolates were assigned to ST599 (differs from ST121 by 2 alleles) (Table). ST599 has been reported for methicillin-susceptible isolates from humans in Europe, Asia, and Africa (www.mlst.net). The Figure shows a minimum spanning tree based on 4,197 entries of the S. aureus multilocus sequence type database (http://saureus.mlst.net/) as of January 19, 2012 (Figure, panel A) and a detailed view of the branches and STs harboring strains with the novel mecA homologue published (Figure, panel B) (3–5).
Microarray hybridization data revealed that the agr type I and capsule type 5 seem to be associated with ST599 and agrIII and that clonal complex (CC) 130 isolates harbor the capsule type 8 encoding gene. CC130 and ST599 isolates were positive for the surface-associated proteins clfA, clfB, fnbA, and bbp. All ST599 strains produced a positive hybridization result for 1 of the gene variants encoding the toxin responsible for toxic shock syndrome (tst1 or tst-bov), and all but 1 of them harbored the enterotoxins C (sec) and L (sel), indicating the presence of an S. aureus pathogenicity island that encodes superantigens (13). Positive or ambiguous hybridization signals for ccrB1, ccrA3, and ccrB3 were obtained for 5 isolates, suggesting the presence of the SCCmecXI in those strains, according to the results of Shore et al. (4).
Our findings of CC130 and ST599 MRSA harboring mecALGA251 in several companion animal species suggest that in Germany, the presence of the mecA homologue in MRSA is not exclusively associated with CC130. This finding supports the hypothesis that some, if not all, MRSA strains that harbor the novel mecA variant can cause infections among a broad variety of hosts, as has been shown for MRSA of human, equine, canine, and other companion animal origins (1,7). All currently known mecALGA251–carrying MRSA were observed in a distinct section of the S. aureus population (Figure, panel B). Whether this phylogenetic group possesses the ability to integrate the novel mecA variant needs to be further investigated.
In the past, mecALGA251–carrying MRSA could have been misidentified as methicillin sensitive by routine PCR. However, all isolates were correctly identified as MRSA by the VITEK 2 system, as reported (4).
Of the 10 isolates, 7 were found in specimens from cats. A recent study identified cats as a potential natural reservoir for S. aureus of CC133, a genetic lineage that has also been reported for S. aureus of ruminant origin (14). Moreover, we have identified a CC130 strain (MSSA_ST2024, t8403) from a wild rat (IMT21250; ID4035) (www.mlst.net). In addition, CC130 MRSA containing the mecA homologue has only recently been reported for isolates from humans in Germany (5).
Although many investigators focus on livestock-associated MRSA, and because particular companion animal lineages of MRSA seem to be lacking, transmission of MRSA between companion animals and human family members in close proximity might be underestimated, especially in cases of recurrent infection (15). The emergence of MRSA harboring the novel mecA homologue has consequences for the verification methods for MRSA used in veterinary medicine; implementation of new methods will be inevitable. Their supposed restriction to only a few genetic lineages and the potential risk for interspecies transmission of atypical MRSA between companion animals and their owners in household environments needs further elucidation.
Dr Walther is a veterinarian holding a postdoctoral position at the Institute of Microbiology and Epizootics in the Infectious Disease Diagnostics and Molecular Epidemiology Working Group. Her primary research interests focus on molecular epidemiology of MRSA and methicillin-resistant S. pseudintermedius in companion animals.
We thank Christel Simon and Sylwia Marquardt for their excellent technical assistance and Matthias Stange and Mario Heising for help with rat sampling.
This work was conducted at the Freie Universität Berlin, Institute of Microbiology and Epizootics and Vet Med Labor GmbH, Ludwigsburg, Germany. It was supported by grants of the German Federal Ministry of Education and Research, MedVet-Staph grant no. 01KI1014F and FBI-Zoo grant no. 01KI1012A, and by the German Research Foundation, GRK1673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Wieler LH, Ewers C, Guenther S, Walther B, Lübke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)–producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol. 2011;301:635–41.
- Pinho MG, de Lencastre H, Tomasz A. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci U S A. 2001;98:10886–91.
- García-Alvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11:595–603.
- Shore AC, Deasy EC, Slickers P, Brennan G, O’Connell B, Monecke S, Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011;55:3765–73.
- Cuny C, Layer F, Strommenger B, Witte W. Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS ONE. 2011;6:e24360.
- Sung JM, Lloyd DH, Lindsay JA. Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray. Microbiology. 2008;154:1949–59.
- Walther B, Monecke S, Ruscher C, Friedrich AW, Ehricht R, Slickers P, Comparative molecular analysis substantiates a zoonotic potential of equine methicillin- resistant Staphylococcus aureus (MRSA). J Clin Microbiol. 2009;47:704–10.
- Merlino J, Watson J, Rose B, Beard-Pegler M, Gottlieb T, Bradbury R, Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non–multidrug-resistant Staphylococcus aureus in central Sydney, Australia. J Antimicrob Chemother. 2002;49:793–801.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard. Wayne (PA); 2008.
- Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–15.
- Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41:5442–8.
- Monecke S, Kuhnert P, Hotzel H, Slickers P, Ehricht R. Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle. Vet Microbiol. 2007;125:128–40.
- Fitzgerald JR, Monday SR, Foster TJ, Bohach GA, Hartigan PJ, Meaney WJ, Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J Bacteriol. 2001;183:63–70.
- Sasaki T, Tsubakishita S, Tanaka Y, Ohtsuka M, Hongo I, Fukata T, Population genetic structures of Staphylococcus aureus isolates from cats and dogs in Japan. J Clin Microbiol. 2012;50:2152–5.
- Rutland BE, Weese JS, Bolin C, Au J, Malani AN. Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis. 2009;15:1328–30.
Suggested citation for this article: Walther B, Wieler LH, Vincze S, Antão E-M, Brandenburg A, Stamm I, et al. MRSA variant in companion animals. Emerg Infect Dis [Internet]. 2012 Dec [date cited]. http://dx.doi.org/10.3201/eid1812.120238
- Page created: November 20, 2012
- Page last updated: November 20, 2012
- Page last reviewed: November 20, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)